StimLabs, LLC
StimLabs is a pioneering company in regenerative medicine, focusing on wound care and surgical applications. They develop innovative biologic solutions, including placental-derived products and human umbilical cord-based devices, to address unmet clinical needs. Their mission is to advance the state of regenerative medicine with high-quality, effective products and services that support physicians and improve patient outcomes.
Industries
Nr. of Employees
medium (51-250)
Patents
Translucent, dehydrated placental tissue and methods of producing and using the same
US-11744918-B2
View DetailsTranslucent, dehydrated placental tissue and methods of producing and using the same
US-11738115-B2
View DetailsTranslucent, dehydrated placental tissue and methods of producing and using the same
US-11154641-B2
View Details
Translucent, dehydrated placental tissue and methods of producing and using the same
US-11744918-B2
View DetailsTranslucent, dehydrated placental tissue and methods of producing and using the same
US-11738115-B2
View DetailsTranslucent, dehydrated placental tissue and methods of producing and using the same
US-11154641-B2
View DetailsProducts
Dehydrated complete human placental membrane allografts (office and hospital formats)
Dehydrated placental membrane allografts supplied in multiple configurations intended for wound coverage, barrier applications, and surgical reconstruction.
Umbilical cord-derived particulate ECM device (hospital-based particulate device)
Dehydrated umbilical cord extracellular matrix particulate device intended to manage acute and chronic wounds; designed for conformability and retention of ECM components.
Porcine-derived advanced wound matrix (office-based advanced wound matrix)
Porcine-derived advanced wound matrix product offered for office-based wound care applications.
Dehydrated complete human placental membrane allografts (office and hospital formats)
Dehydrated placental membrane allografts supplied in multiple configurations intended for wound coverage, barrier applications, and surgical reconstruction.
Umbilical cord-derived particulate ECM device (hospital-based particulate device)
Dehydrated umbilical cord extracellular matrix particulate device intended to manage acute and chronic wounds; designed for conformability and retention of ECM components.
Porcine-derived advanced wound matrix (office-based advanced wound matrix)
Porcine-derived advanced wound matrix product offered for office-based wound care applications.
Services
Educational resources and support for clinicians on clinical use of tissue-derived regenerative products.
Support services for insurance verification and reimbursement related to regenerative tissue product use.
Online portal for providers to access account, ordering, or product resources.
Educational resources and support for clinicians on clinical use of tissue-derived regenerative products.
Support services for insurance verification and reimbursement related to regenerative tissue product use.
Online portal for providers to access account, ordering, or product resources.
Expertise Areas
- Regenerative medicine focused on placental- and umbilical cord-derived biologics
- Wound management and surgical barrier product development
- Tissue processing and manufacturing scale-up
- Regulatory compliance and 510(k) submission strategy
Key Technologies
- Dehydrated placental membrane allografts
- Umbilical cord extracellular matrix particulate devices
- Extracellular matrix (ECM) preservation and characterization
- Tissue dehydration and preservation methods
News & Updates
StimLabs announces FDA 510(k) clearance of Corplex P, a human umbilical cord-derived medical device for wound management, marking a significant milestone in the industry.
StimLabs shares its achievements and growth in 2020, including product launches, expansion of staff and facilities, and increased revenue.
StimLabs has been at the forefront of regenerative medicine, launching placental-derived products and developing innovative solutions.
An exploration of homeostasis and the importance of balance in health and healing.
An overview of the complex healing cascade and the role of regenerative solutions.
StimLabs shares its perspective and engages with clinicians, scientists, and patients through its blog.
StimLabs announces FDA 510(k) clearance of Corplex P, a human umbilical cord-derived medical device for wound management, marking a significant milestone in the industry.
StimLabs shares its achievements and growth in 2020, including product launches, expansion of staff and facilities, and increased revenue.
StimLabs has been at the forefront of regenerative medicine, launching placental-derived products and developing innovative solutions.
An exploration of homeostasis and the importance of balance in health and healing.
An overview of the complex healing cascade and the role of regenerative solutions.
StimLabs shares its perspective and engages with clinicians, scientists, and patients through its blog.